{
  "nct_id": "NCT86361477",
  "indication": "Major Depressive Disorder",
  "phase": "Phase 2",
  "sample_size": 296,
  "duration_weeks": 42,
  "dropout_rate": 0.28,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "MADRS score reduction"
  ],
  "secondary_endpoints": [
    "HAM-D score reduction",
    "Response rate"
  ],
  "outcome_summary": "No significant difference compared to placebo",
  "success": 0,
  "failure_reason": "Dose selection suboptimal",
  "start_date": "2024-04-21",
  "completion_date": "2025-02-09"
}